Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 12, 2021
Humanized Biomimetic Nanovesicles for Neuron TargetingAssaf Zinger, Caroline Cvetkovic, Manuela Sushnitha, et al.
Translational Oncology|April 9, 2024
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approachAustin T K Hoke, Yoko Takahashi, Michelle R Padget, et al.
Science Signaling|January 27, 2026
EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancerNaijiang Liu, Xiaojie Shi, Shao-Rui Chen, et al.
Journal for Immunotherapy of Cancer|August 21, 2023
TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinomaYewen Shi, Xiaoyong Ren, Shaolong Cao, et al.
Communications Biology|July 28, 2022
Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinomaYewen Shi, Tongxin Xie, Bingbing Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 4, 2022
Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiologyMoran Amit, Tongxin Xie, Frederico O Gleber-Netto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent MannerPhillip M Pifer, Liangpeng Yang, Manish Kumar, et al.
JCO Precision Oncology|June 7, 2023
Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck CancerHannah Y Chen, Weilu Zhao, Shorook Na'ara, et al.
International Journal of Radiation Biology|February 20, 2020
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpointsJessica M Molkentine, David P Molkentine, Kathleen A Bridges, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 10, 2026
β-Adrenergic Signaling Promotes Anti-Tumor Immunity in TP53-mutant Oral Squamous Cell CarcinomaFrederico O Gleber-Netto, Deborah Silverman, Tongxin Xie, et al.
Pageof 3